Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1063 results about "CSF - Cerebrospinal fluid" patented technology

Cerebrospinal fluid (CSF) is a clear, colorless body fluid found in the brain and spinal cord. It is produced by the specialised ependymal cells in the choroid plexuses of the ventricles of the brain, and absorbed in the arachnoid granulations.

Method and apparatus for surgical training

InactiveUS20030186203A1Educational modelsDecreased mean arterial pressureArterial cannulation
An apparatus and method for microsurgical training using cadaveric anatomy with filling of the vascular system by fluids under pressure to simulate the appearance and function of live surgery. One or more arteries on the specimen of cadaveric anatomy are cannulated and connected to an arterial reservoir having a flexible container holding an arterial fluid simulating the appearance of blood circulating in the arteries of the living organism from which the cadaveric anatomy is derived. Suitable static pressure simulating the arterial pressure appropriate to that of the living organism is applied to the air in an air-tight space surrounding the flexible container in the arterial reservoir. A pulsating machine provides air pulsations to the space surrounding the flexible fluid container to simulate the normal pulsations of the arterial system. One or more veins on the specimen are also cannulated and connected to a venous reservoir having a flexible container holding a venous fluid simulating the appearance of blood circulating in the veins of the living organism. Suitable static pressure simulating the venous pressure appropriate to that of the living organism is applied to the air in an air-tight space surrounding the flexible container in the venous reservoir. Optionally, if the specimen includes at least a portion of spinal canal, a clear fluid reservoir can be connected to the specimen through the spinal canal to simulate cerebrospinal fluid.
Owner:ABOUD GHAITH +1

Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure

Methods for simultaneous injection and aspiration of fluids during a medical procedure are disclosed. Embodiments include methods for operating medical devices within the subarachnoid space of the spinal column to gain access to the ventricles of the brain, as well as the surrounding cranial subarachnoid space. A dual lumen constant volume aspiration catheter is disclosed that injects a volume of injectable fluid to break up an obstruction within the brain or cranial subarachnoid space while simultaneously aspirating a same volume of aspirated fluid from the treatment site. Methods hereof include constant volume re-circulation of cerebral spinal fluid to and from a treatment area within one of the brain and the surrounding cranial subarachnoid space, which may be desirable during a ventriculostomy.
Owner:MEDTRONIC VASCULAR INC

Surgically implantable hearing aid

The invention comprises a surgically implantable hearing aid for hearing impaired persons. The hearing aid includes a vibrational element which is vibrated by sound waves and attached to the skull of the person, and a connector which crosses the mastoid cavity and delivers the sound waves to the dura mater of the human being thereby vibrating the dura mater, the cerebrospinal fluids, and the brain to create a hearing percept. The invention can also be adapted to act as a tinnitus masker or used in conjunction with a cochlear implant. It can also be used in a modified form to connect directly through the skull of the human being.
Owner:ALAN J LUPIN

Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases

The invention provides methods for diagnosing, treating, or evaluating inflammatory and autoimmune diseases by sampling peripheral blood, serum, plasma, tissue, cerebrospinal fluid, or other bodily fluids from a human subject having a suspected diagnosis. The sample is analyzed for the presence and amount of certain cytokines, which provides the diagnosis, prognosis or evaluation of therapeutic response.
Owner:THE BOARD OF RGT UNIV OF OKLAHOMA +1

Cerebrospinal fluid puncturing drainer

The cerebrospinal fluid piercing drainer includes a piercing unit and an external draining unit. The piercing unit includes piercing needle, piercing sheath, guide wire and draining pipe. The piercing needle and the outside piercing sheath are made of stainless steel material and are used in piercing; the flexible guide wire of plastic-steel material with shape memory function is used in replacing the piercing needle; the draining pipe of soft silicone gel is used in replacing the piercing sheath and draining. During piercing, the piercing needle and the outside piercing sheath are first pierced into proper position, the piercing needle is then withdrawn and the guide wire is penetrated through the piercing sheath, and the piercing sheath is finally withdrawn and the draining pipe is fed along the guide wire to the cavity to be drained or fed to cerebral side room or even farther position under the monitoring with DSA. The draining pipe has external end connected to the draining unit.
Owner:何明利

Catheters incorporating valves and permeable membranes

Devices, systems and methods for delivering one or more drugs to one or more internal body locations (such as the cerebrospinal fluid) are disclosed. In various aspects, the systems and methods may involve catheters having infusion sections with permeable membranes and one or more valves that control flow to the infusion sections.
Owner:MEDTRONIC INC

Device for the treatment of hydrocephalus

InactiveUS6283934B1Wound drainsIntravenous devicesVentricular cathetersFlow diverter
A cerebrospinal fluid shunt system comprises a brain ventricular catheter for insertion into the brain ventricle so as to drain cerebrospinal fluid from the brain ventricle. The system also comprises a sinus sagittalis catheter for insertion into the sinus sagittalis for feeding the cerebrospinal fluid into sinus sagittalis. A shunt main body is connected at one end thereof to the brain ventricle catheter and at another end thereof to the sinus sagittalis catheter. The shunt main body can provide fluidic communication between the brain ventricle catheter and the sinus sagittalis catheter. The system further comprises a tubular flow passage restricting member defined within the shunt main body. The tubular flow passage restricting member defines a resistance to flow of 8-12 mm Hg / ml / min.
Owner:SINU SHUNT

Cerebrospinal Fluid Purification System

The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF). The methods provide for efficiently removing target compounds from CSF. The systems provide for a multilumen flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents. The invention finds use as a diagnostic, therapeutic and drug delivery platform for a variety of diseases affecting the CNS by accessing the CSF space. Exemplified disease conditions treatable by the present CSF processing systems and methods include, but are not limited to: Cerebral Vasospasm, Guillain Bane Syndrome, illustrating multi-lumen lumbar approach Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Stroke, Cancer affecting the brain or spinal cord, Prion disease, Encephalitis from various causes, Meningitis from various causes, diseases secondary to enzymatic or metabolic imbalances, Biological Warfare, etc. For the first time, the present invention offers patients a disease-modifying, disruptive technology treatment platform that addresses the known disease pathogenesis of a number of neurologic conditions to which there are presently limited and ineffective treatment options.
Owner:NEUROFLUIDICS

Central nervous system cooling catheter

The invention provides a method and apparatus for performing selective hypothermia to the brain and spinal cord for injury protection without the need for systemic cooling. A flexible catheter is inserted into the cerebral lateral ventricle or spinal subdural space. The catheter has lumens with a heat transfer element. The lumens of the catheter circulate a coolant and communicate at the distal heat transfer element for transfer of heat from the cerebrospinal fluid. Furthermore a method of maintaining catheter patency and providing blood clot hemolysis and drainage is also provided through the use of ultrasonic and / or laser energy delivered through the catheter.
Owner:KHANNA ROHIT

Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions

Compositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may also include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer. The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatment such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination with an oil and forms a laminate. In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.
Owner:VERSITECH LTD +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products